The NeuroSolve consortium recently organised a scientific seminar on Taenia solium Neurocysticercosis in Zambia, delivered by Prof. Hugo Garcia from the Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru, an internationally recognised expert in neurocysticercosis research and management. The seminar was part of the ongoing NeuroSolve activities aimed at strengthening knowledge exchange, capacity building, and collaboration among partners involved in the project and was held at the School of Medicine of the University of Zambia.
During the seminar, Prof. Garcia presented an overview of the current understanding of Taenia solium infections and neurocysticercosis, including epidemiology, clinical manifestations, diagnostic challenges, and treatment strategies. Particular attention was given to the burden of the disease in endemic regions and to the importance of improving access to accurate diagnosis and effective treatment.
The event brought together clinicians, researchers, interns, students, and health professionals involved in the NeuroSolve project, providing an opportunity to discuss current challenges in the management of neurocysticercosis and the role of implementation research in improving patient care.
In addition to the seminar, Prof. Garcia visited the NeuroSolve clinical trial sites in Zambia, where project activities on the diagnosis and treatment of neurocysticercosis are currently ongoing. The visit allowed direct interaction with local research teams and health workers, as well as discussion of the progress of the study and the practical challenges encountered in the field.
These visits are an important component of the NeuroSolve project, as they support capacity building, strengthen collaboration among partners, and ensure that research activities are aligned with the realities of clinical practice in endemic settings.
Through initiatives such as this seminar and site visits, NeuroSolve continues to promote the exchange of expertise and the development of sustainable approaches for the control and management of neurocysticercosis.
